Let’s see if this sounds familiar…
You finally have a name for what’s been happening in your body. Maybe it took years to get that diagnosis. Maybe you fought for it. Maybe someone handed it to you almost as an afterthought at the end of a fifteen-minute appointment.
But you had the name. PCOS. And that name – imperfect as it was – connected you to a community, to answers, to other women who finally got it.
And now the name is changing.
After more than a decade of debate, 22,000 survey responses, and a global consensus process published in The Lancet, polycystic ovary syndrome has been officially renamed Polyendocrine Metabolic Ovarian Syndrome.
PMOS.
I have been following this conversation for a long time. I participated in the process and voted.
And I have real thoughts about what this gets right, where I personally landed, and what it actually means for you and your care. (Not the press release version. The real version.)
Let’s get into it.
First – why did PCOS ever need a new name?
Here’s the thing about the old name. It was never exactly wrong.
It was incomplete and in medicine, incomplete language has consequences.
When a condition is named after one feature, the ovaries, that’s where attention goes. That’s where research funding goes. That’s where the clinical conversation starts and, too often, ends.
Meanwhile, the women living with it were experiencing something that was never just about their ovaries:
• Insulin resistance that changed how their body responded to food and energy
• Chronic inflammation running quietly in the background – affecting skin, mood, energy, and that 2pm brain fog that steals entire afternoons
• Androgen excess showing up in ways nobody connected to each other
• Metabolic risk going completely unaddressed because nobody was looking for it
• Mental health impacts that were real, documented, and almost never part of the appointment
The name PCOS didn’t tell that story.
And because it didn’t tell that story, providers weren’t always looking for it. Researchers weren’t always funded to study it. Women were leaving appointments with a partial picture of a condition that was affecting their whole body.
That’s why this matters and that’s why I hope this name change is just the beginning.
Here’s where I personally landed and I’m going to be transparent about this
I want to be honest with you about something, because I think it matters.
My vote was not for a completely new name.
My vote was to keep the acronym and change what it stands for.
Because here’s what concerns me about PMOS and I say this even as someone who believes the science behind this decision is completely sound:
PCOS has global recognition built over decades. Women know that acronym. They search it. They find their community under it. They finally have language for something that’s been happening in their body – sometimes for years, sometimes for most of their life and that language connects them to each other, to providers, to answers.
When a newly symptomatic woman sits in an appointment next year and someone mentions this condition… will she go home and search PMOS? Will her primary care provider even use that term yet? Will the support group she finds online have made the transition?
(Spoiler: terminology changes in medicine are slower than anyone wants to admit. Clinical guidelines lag. Insurance codes often take years to update.)
What I wanted was a name that kept the recognition and changed the meaning. Keep the letters. Change the story they tell. PCOS could have stood for something that reflected the endocrine and metabolic reality without asking 170 million women worldwide to learn a new acronym from scratch.
That was my position. It didn’t carry the vote.
However, I respect the process that got us here even where I disagree with the outcome.
What PMOS gets right and this part really matters
Okay. Now that I’ve been honest about my concerns, I want to be equally clear about this: The science behind this decision is sound and the intention is exactly right. Polyendocrine Metabolic Ovarian Syndrome is a name that tells a truer story.
It says from the start that this condition involves the endocrine system: hormones, signaling, and the entire communication network your body runs on. It says metabolism is central, not incidental. It says the ovaries are part of the picture without making them the whole picture.
That framing? That’s what I’ve been working from for years.
In every coaching session, every conversation I have with a woman navigating this, I’m always talking about the whole body. The insulin piece. The inflammatory piece. The stress response. As well as, the oral health connection that almost never makes it into the PCOS conversation, even though gum inflammation contributes to the systemic inflammatory load this condition is already carrying. (Yes, really. Your mouth is part of this picture.)
PMOS validates that whole body lens in a way the old name never quite did.
And if that shift in name changes how even one provider approaches the next woman who walks through the door – if it prompts them to look at metabolic markers they weren’t checking, to flag cardiovascular risk they weren’t seeing, to see the full picture instead of just the ovaries then something genuinely important has happened.
Not just for research. For the woman in the room.
The bigger opportunity hiding inside this moment
Here’s what I’m most hopeful about.
When a condition is named accurately, everything downstream has a chance to shift.
Research gets funded differently. Grant applications get written differently. Clinical guidelines get built around the full scope of what the condition actually is rather than the narrow slice the old name implied.
For decades, PCOS research has been underfunded relative to its prevalence. One in eight women. 170 million people worldwide. Yet the treatment options available to most women are limited in ways that feel completely out of proportion to how many people are affected.
That is not a coincidence.
It’s connected to how the condition has been categorized, named, and therefore perceived by the institutions that decide where research dollars go.
PMOS opens a door.
A condition framed as a multi system endocrine and metabolic disorder attracts different funding conversations than one framed as a gynecological issue with some hormonal components. It belongs in different research departments. It sits at the intersection of endocrinology, cardiology, metabolic medicine, and reproductive health simultaneously. And naming it that way gives researchers and advocates the language to make that case.
I hope that door leads to more treatment options that address underlying mechanisms rather than just managing symptoms. More clinical guidelines that account for the full picture. More providers trained to see this as the whole-body experience it has always been.
The women I work with deserve that. All 170 million of us do.
What this means for you right now, today
Whether you’ve been calling this PCOS for ten years or you just heard the word PMOS for the first time today, this name change is an invitation.
An invitation to see your condition the way the researchers who study it most closely now see it.
Not just a reproductive issue you’ll deal with when you want children. Not a hormonal imbalance that mostly affects your cycle. Not a weight problem with a complicated name.
A whole body, multi system, complex, real condition that deserves a whole body approach. That means looking at the full picture:
• Your insulin and blood sugar patterns
• Your inflammatory markers
• Your cardiovascular risk
• Your mental health and stress response
• Your sleep
• And your oral health because the mouth is part of the immune system, and gum inflammation is a source of systemic inflammation that compounds everything else this condition is already doing
None of those pieces exist in isolation. They never did.
The new name just makes that harder for anyone to ignore.
If your care up until now has felt fragmented, if you’ve been treated symptom by symptom without anyone connecting the dots, this is the moment to ask for more. More context. More conversation. A fuller picture.
You’ve always deserved that. Now the language of the condition you’re living with finally says so too.
What doesn’t change
The condition is the same. The mechanisms are the same. The women navigating it are the same.
Insulin resistance still drives androgen excess. Inflammation still runs through the picture. The appointment is still too short, and the gap between diagnosis and real support is still too wide.
A new name doesn’t close that gap.
Better care does. A full picture does. Support that sees the whole body not just the parts that fit neatly into a single specialty does.
I’ll keep using PCOS in conversations where that’s the word women know. I’ll introduce PMOS where it helps. And I’ll keep doing what I’ve always done: helping women understand what this condition is actually doing in their specific body and what it means for their real life.
That part doesn’t need a new name.
Ready to see your full picture?
If this has you thinking about your own diagnosis, about what a whole body approach would actually look like for you specifically, that conversation is exactly what I’m here for.
I’m Christine, your PMOS/PCOS health coach and dental hygienist at Fusion Health Coaching. I provide integrated support that connects medical, dental, and lifestyle health into a whole body picture that most providers never put together.
Right now I have a free 30-minute PMOS Strategy Session where we talk about your body, your symptoms, and what your next best step actually looks like.
No pressure. No sales pitch. Just an honest conversation.
